Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings

Summary

The resolution asks the Alabama Medicaid Agency to evaluate the overall cost of providing GLP‑1 medications for weight management, consider potential savings from new federal drug‑pricing models, and discuss findings with providers. It would affect roughly 110,000 Medicaid adults and children who might qualify for these drugs and aims to guide future coverage decisions. The agency must deliver a report to the Legislature before the 2027 session.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share